European consumer electronics group Philips expects full year sales at its medical systems business in the range of six to 6.5 billion euros (U.S. $7.0 billion), Jan Hommen, CFO, said on Tuesday.
Mr. Hommen, who was speaking at an analysts' conference, said these were ballpark figures and that he expected sales to reach 1.5 billion euros ($1.6 billion) in the second quarter.
Philips targets chips research and development spending of 16-18 percent of total sales at the chip unit. Mr. Hommen said Philips' long term objective is 16-18 percent.
Over the past 2 years, spending was higher than 20 percent. (Reuters)
Back to Breaking News